Trump Admin Delays Penalties For Drug Price Overcharges
The Trump administration has delayed the implementation of a rule that would penalize drug manufacturers for overcharging certain health care providers, such as those that treat children and cancer patients, saying...To view the full article, register now.
Already a subscriber? Click here to view full article